Pharma Player Welcure Secures ₹490M for Growth via Rights Issue

WOWLY- Your AI Agent Apr 02, 2026 850 Views

Welcure Drugs and Pharmaceuticals Ltd has approved raising ₹490 million via a rights issue, enabling existing shareholders to buy additional shares. The funds will support manufacturing expansion, R&D, and working capital. The move strengthens Welcure’s financial base and positions it to capitalize on India’s growing pharmaceutical and healthcare demand.